EA200500328A1 - Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства - Google Patents

Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства

Info

Publication number
EA200500328A1
EA200500328A1 EA200500328A EA200500328A EA200500328A1 EA 200500328 A1 EA200500328 A1 EA 200500328A1 EA 200500328 A EA200500328 A EA 200500328A EA 200500328 A EA200500328 A EA 200500328A EA 200500328 A1 EA200500328 A1 EA 200500328A1
Authority
EA
Eurasian Patent Office
Prior art keywords
diseases
asthma
treatment
chronic obstructive
obstructive pulmonary
Prior art date
Application number
EA200500328A
Other languages
English (en)
Other versions
EA008981B1 (ru
Inventor
Роберт Герман
Матиас Лохер
Original Assignee
Виатрис Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виатрис Гмбх Унд Ко. Кг filed Critical Виатрис Гмбх Унд Ко. Кг
Publication of EA200500328A1 publication Critical patent/EA200500328A1/ru
Publication of EA008981B1 publication Critical patent/EA008981B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Изобретение относится к новой комбинации глюкокортикоида, в частности лотепреднола, и по меньшей мере одного ингибитора фосфодиэстеразы-4 (ингибитора PDE-4), в частности гидроксииндольного производного N-(3,5-дихлорпиридин-4-ил)-2-[1-(4-фторбензил)-5-гидроксииндол-3-ил]-2-оксоацетамида для одновременного, последовательного или раздельного введения при лечении респираторных заболеваний, аллергических заболеваний, астмы и хронических заболеваний, связанных с закупориванием легочной артерии (COPD).Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500328A 2002-08-09 2003-08-04 Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства EA008981B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10236688 2002-08-09
PCT/EP2003/008607 WO2004019984A1 (de) 2002-08-09 2003-08-04 Neue kombination von glucocorticoiden und pde-4-inhibitoren zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd

Publications (2)

Publication Number Publication Date
EA200500328A1 true EA200500328A1 (ru) 2005-06-30
EA008981B1 EA008981B1 (ru) 2007-10-26

Family

ID=31968961

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500328A EA008981B1 (ru) 2002-08-09 2003-08-04 Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства

Country Status (19)

Country Link
US (1) US20050288265A1 (ru)
EP (1) EP1526870B1 (ru)
JP (1) JP2005539042A (ru)
CN (1) CN1308038C (ru)
AT (1) ATE361076T1 (ru)
AU (1) AU2003255365B2 (ru)
CA (1) CA2492645A1 (ru)
CY (1) CY1107696T1 (ru)
DE (1) DE50307184D1 (ru)
DK (1) DK1526870T3 (ru)
EA (1) EA008981B1 (ru)
ES (1) ES2285238T3 (ru)
HK (1) HK1078463A1 (ru)
HR (1) HRP20050224B1 (ru)
MX (1) MXPA05001573A (ru)
NO (1) NO20051212D0 (ru)
PT (1) PT1526870E (ru)
UA (1) UA82323C2 (ru)
WO (1) WO2004019984A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10241407A1 (de) * 2002-09-06 2004-03-18 Elbion Ag Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe
WO2005074918A1 (en) 2004-02-06 2005-08-18 Benzstrasse 1 D-61352 Bad Homburd The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
PL1713471T3 (pl) 2004-02-06 2012-06-29 Meda Pharma Gmbh & Co Kg Kombinacja środków antycholinergicznych i inhibitorów fosfodiesterazy typu 4 do leczenia chorób oddechowych
JP4991693B2 (ja) 2005-03-16 2012-08-01 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
JP5107933B2 (ja) 2005-12-21 2012-12-26 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 炎症性疾患の治療に使用する、抗コリン作用薬類、β２−アドレナリン受容体のアゴニスト類、抗ロイコトリエン（ロイコトリエン受容体のアンタゴニスト）類、グルココルチコイド類および／またはＰＤＥ４阻害剤類の新規配合薬
JP2009529053A (ja) * 2006-03-07 2009-08-13 コンビナトアールエックス インコーポレーティッド 免疫炎症性障害の処置のための組成物および方法
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN102309756A (zh) * 2010-07-02 2012-01-11 天津金耀集团有限公司 含有磷酸二酯酶4抑制剂和糖皮质激素的治疗皮肤病的复方药物
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
EP4008355A1 (en) 2012-05-03 2022-06-08 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
WO2013166408A1 (en) * 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US10864219B2 (en) 2012-05-03 2020-12-15 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US20160030435A1 (en) * 2013-03-15 2016-02-04 Robert I HENKIN Phosphodiesterase inhibitor treatment
WO2015126944A1 (en) 2014-02-18 2015-08-27 Henkin Robert I Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
EP1014943B1 (de) * 1997-02-05 2002-06-19 Jago Research Ag Medizinische aerosolformulierungen
DE19917504A1 (de) * 1999-04-17 2000-10-19 Dresden Arzneimittel Verwendung von Hydroxyindolen, die Inhibitoren der Phosphodiesterase 4 sind, zur Therapie chronisch obstruktiver Lungenerkrankungen
ES2262072T3 (es) * 1998-04-28 2006-11-16 Elbion Ag Derivados de indol y su utilizacion como inhibidores de la fosfodiesterasa 4.
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
ECSP003747A (es) * 1999-11-02 2002-05-23 Smithkline Beecham Corp Metodo y composiciones para el tratamiento de las enfermedades pulmonares
US20040214805A1 (en) * 1999-11-02 2004-10-28 Smithkline Beecham Corporation Method and compositions for treating pulmonary diseases
PT1289945E (pt) * 2000-05-19 2004-10-29 Alcon Inc Derivados dissulfureto de anilina para o tratamento de doencas alergicas
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
CN1585641A (zh) * 2001-11-05 2005-02-23 默克专利有限公司 亚肼基－丙二腈化合物
US20030092706A1 (en) * 2001-11-09 2003-05-15 Johannes Barsig Combination

Also Published As

Publication number Publication date
HK1078463A1 (en) 2006-03-17
US20050288265A1 (en) 2005-12-29
CN1308038C (zh) 2007-04-04
DE50307184D1 (de) 2007-06-14
WO2004019984A1 (de) 2004-03-11
ATE361076T1 (de) 2007-05-15
JP2005539042A (ja) 2005-12-22
EP1526870A1 (de) 2005-05-04
HRP20050224B1 (en) 2007-12-31
CN1674939A (zh) 2005-09-28
HRP20050224A2 (en) 2005-04-30
NO20051212L (no) 2005-03-08
UA82323C2 (ru) 2008-04-10
MXPA05001573A (es) 2005-04-25
AU2003255365A1 (en) 2004-03-19
PT1526870E (pt) 2007-07-09
CY1107696T1 (el) 2013-04-18
EA008981B1 (ru) 2007-10-26
CA2492645A1 (en) 2004-03-11
DK1526870T3 (da) 2007-09-10
AU2003255365B2 (en) 2009-02-19
NO20051212D0 (no) 2005-03-08
ES2285238T3 (es) 2007-11-16
EP1526870B1 (de) 2007-05-02

Similar Documents

Publication Publication Date Title
CY1107696T1 (el) Συνδιασμος εταβονικης λοτεπρεδνολης και dfho για την αντιμετωπιση αναπνευστικων παθησεων, αλλεργικων παθησεων, ασθματος και copd
CA2474479A1 (en) Composition for inhalation
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
WO2005041864A3 (en) Combination of cyclooxygenase-2 inhibitor and phosphodiesterase 4 inhibitor and method
IS2575B (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
NO20053023L (no) Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol
MXPA04007294A (es) Composicion para inhalacion.

Legal Events

Date Code Title Description
PD1A Registration of transfer to a eurasian application by order of succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU